β-Lactam/β-Lactamase Inhibitor Combinations Non-Susceptible ESBL-Producing Enterobacteriaceae Bloodstream Infections: An Underestimated Clinical Entity
Given the high prevalence and mortality of BnESBL-E-BSI, carbapenems may be preferable treatment option for non-urinary ESBL-E-BSIs. BnESBL-E represents an underestimated clinical threat, warranting timely identification of risk factors and the consideration of appropriate empirical therapy.
Authors
- Tingting Qu (ORCID: https://orcid.org/0000-0002-9787-9220)
- Hongchao Chen (ORCID: https://orcid.org/0000-0001-8367-1464)
- Shuangling Ni
- Hangbin Hu (ORCID: https://orcid.org/0000-0003-4804-4187)
- Sheng Zhang (ORCID: https://orcid.org/0000-0003-0462-6724)
- Yan Zhang (ORCID: https://orcid.org/0000-0003-2189-0244)
- Meihong Yu
- Lingmei Ni
- Qing Yang (ORCID: https://orcid.org/0000-0003-3744-9402)
- Haiting Feng
Institutions
- Lishui City People's Hospital (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- National Center for Infectious Diseases (US)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/idr.s514373
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.59
Funders
- National Key Research and Development Program of China